State Street’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.75M | Buy |
831,819
+30,562
| +4% | +$138K | ﹤0.01% | 3061 |
|
|
2025
Q1 | $3.72M | Sell |
801,257
-275,173
| -26% | -$1.28M | ﹤0.01% | 2994 |
|
|
2024
Q4 | $7.47M | Buy |
1,076,430
+388,853
| +57% | +$2.7M | ﹤0.01% | 2776 |
|
|
2024
Q3 | $3.64M | Buy |
687,577
+51,493
| +8% | +$273K | ﹤0.01% | 3100 |
|
|
2024
Q2 | $2.38M | Buy |
636,084
+20,833
| +3% | +$77.9K | ﹤0.01% | 3254 |
|
|
2024
Q1 | $4.34M | Buy |
615,251
+41,842
| +7% | +$295K | ﹤0.01% | 2985 |
|
|
2023
Q4 | $3.24M | Sell |
573,409
-19,349
| -3% | -$109K | ﹤0.01% | 3137 |
|
|
2023
Q3 | $2.84M | Sell |
592,758
-2,277
| -0.4% | -$10.9K | ﹤0.01% | 3177 |
|
|
2023
Q2 | $4.08M | Buy |
595,035
+64,289
| +12% | +$440K | ﹤0.01% | 3094 |
|
|
2023
Q1 | $4.13M | Buy |
530,746
+13,370
| +3% | +$104K | ﹤0.01% | 3062 |
|
|
2022
Q4 | $3.94M | Buy |
517,376
+32,805
| +7% | +$250K | ﹤0.01% | 3134 |
|
|
2022
Q3 | $3.96M | Buy |
484,571
+33,707
| +7% | +$275K | ﹤0.01% | 3170 |
|
|
2022
Q2 | $4.36M | Buy |
450,864
+81,296
| +22% | +$786K | ﹤0.01% | 3160 |
|
|
2022
Q1 | $5.18M | Buy |
369,568
+169,992
| +85% | +$2.38M | ﹤0.01% | 3164 |
|
|
2021
Q4 | $4.08M | Buy |
199,576
+48,034
| +32% | +$981K | ﹤0.01% | 3340 |
|
|
2021
Q3 | $3.38M | Buy |
+151,542
| New | +$3.38M | ﹤0.01% | 3434 |
|